Arviat Pharmaceuticals, Inc.
PrivateLast Round
Seed
Jan 1, 2020
Total Funding Raised
$450,060
Company Overview
Arviat Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. It has raised $450,060.
Arviat Pharmaceuticals, Inc. is a biotechnology company that develops oral small-molecule inhibitors targeting neuroinflammation to treat Alzheimer's and other adult neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arviat Pharmaceuticals, Inc. Comparables
Compare Arviat Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acurex Biosciences | 83% | |
| Monument Biosciences | 82% | |
| NeuroTherapia, Inc. | 78% |
For institutional investors. Book with your work email.
Arviat Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Arviat Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Arviat Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arviat Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Arviat Pharmaceuticals, Inc. a public or private company?
Arviat Pharmaceuticals, Inc. is a private company.
What is the current stock price of Arviat Pharmaceuticals, Inc.?
Arviat Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Arviat Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arviat Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Arviat Pharmaceuticals, Inc. is not publicly available.
Can I buy Arviat Pharmaceuticals, Inc. stock?
Arviat Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arviat Pharmaceuticals, Inc.'s last funding round?
Arviat Pharmaceuticals, Inc.'s most recent funding round was Seed on January 1, 2020.
Who are the main investors in Arviat Pharmaceuticals, Inc.?
Key investors in Arviat Pharmaceuticals, Inc. include National Institute on Aging.
Will Arviat Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Arviat Pharmaceuticals, Inc..
How can I track Arviat Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Arviat Pharmaceuticals, Inc.'s shares on secondary markets.